This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation - PDA Call 19 Stage 1 Minutes

 

Contents

Minutes of the Product Development Awards Competition 19 Stage 1 Sub-Committee Meeting

 Wednesday 5 February 2020

at

LGC Ltd, Grange House, 15 Church Street, Twickenham TW1 3NL

 

In attendance:

Funding Committee 

Mr Mark Kirby (Chair)

 

Professor Paul Sibbons (Deputy Chair)

 

Mr Charles Spicer (Chair)

 

Professor David Hawkes (Deputy Chair)

 

i4i Secretariat

Apologies

Mr Martin Hunt (Programme Director)

Mr Ben Patient (Director of Innovations)

Dr Ruth Nebauer (Assistant Director)

Dr Ian Newington

Dr Andrew Barber

Dr Fanny Burrows

Dr Emma Blamont

 

Mr Freddy Guenemi

 

Dr Katherine Horner

Observers

Mr Thomas Hutchinson

Jacob Holderness

Dr Caterina Lombardo

Mrs Samantha Wade

Mrs Paula Milton

 

Dr Sandra Nwokeoha

 

Dr Raffaella Roncone

 

Mr Edwin Tucker

 
   

 



Stage 1 applications to be invited to submit to Stage 2 as follows:

NIHR201688: ChromaDose: In-vitro diagnostic device development and validation, enabling point-of-care therapeutic drug monitoring for dose optimisation of anthracycline chemotherapy in paediatric cancer settings.

 

Outcome:  Invited to submit stage 2 application

 

NIHR201655: “CEeDD: “A First-in-Human Clinical Investigation of Cavitation-Enhanced Drug Delivery to Solid Tumours by co-Administration of Sonosensitive Particles and Application of Extracorporeal Ultrasound in Patients with Colorectal Metastases to the Liver”

 

Outcome: Invited to submit stage 2 application

 

NIHR201684: Development and clinical study of a wearable brain imaging device to detect intracranial bleeding at the point of care

 

Outcome: Invited to submit stage 2 application

 

NIHR201671: Digital Histopathology Screening Platform

 

Outcome:  Invited to submit stage 2 application

 

NIHR201646: Implantable Lymph Node Substitute for Prevention of Surgically-Induced Lymphoedema

 

Outcome:  Invited to submit stage 2 application

 

NIHR201625: Prevent bone fracture during or shortly after hip replacement surgery

 

Outcome:  Invited to submit stage 2 application

 

NIHR201632: Investigating non-invasive diagnosis and monitoring in gestational diabetes (INDiGo study)

 

Outcome:  Invited to submit stage 2 application

 

NIHR201642: A new therapy for post-stroke arm spasticity: Sheffield Adaptive Patterned Electrical Stimulation (SHAPES) - a co-designed system improvement followed by a powered multi-arm randomised control trial.

 

Outcome:  Invited to submit stage 2 application

 

NIHR201629: The development of a chatbot to support successful transition to adult care of young people with Type 1 Diabetes

 

Outcome:  Invited to submit stage 2 application

 

NIHR201641: A Novel Mitral Valve for Transcatheter Implantation

 

Outcome: Invited to submit stage 2 application

 

NIHR201643: SuperResPath-Renal: Quantitative super-resolution technology for a fast, de-centralised clinical diagnosis of renal pathologies

 

Outcome:  Invited to submit stage 2 application

 

NIHR201645: Rapid, Sensitive Detection of Resistance to Therapeutic Antibodies Product Development

 

Outcome:  Invited to submit stage 2 application

 

NIHR201651: Prediction of Atrial Fibrillation using P-wave characteristics – Development of a module for integration into commercially available remote monitoring devices

 

Outcome:  Invited to submit stage 2 application

 

NIHR201654: MorphGI- a self-propelled soft colonoscope

 

Outcome:  Invited to submit stage 2 application

 

NIHR201677:  Refining breast cancer diagnosis and prognosis using artificial intelligence (AI) to solve diagnostic bottleneck and improve patients’ care.

 

Outcome:  Invited to submit stage 2 application

 

NIHR201680: Remote delivery on an app-based intervention DIALOG+ in community mental health care – development of Remote DIALOG+

 

Outcome:  Invited to submit stage 2 application

 

Stage 1 applications not invited to submit to Stage 2 as follows:

NIHR201660: Development and first in-person clinical application of a quantitative ultrasound imaging system for improved breast cancer diagnosis

 

Outcome: Reject

 

NIHR201672:  Development and validation of a sensitive blood test for diagnosis and monitoring osteoarthritis

 

Outcome: Reject

 

NIHR201679: A transformational approach to the early detection of bowel cancer

 

Outcome: Reject

 

NIHR201635: Development of device for assessment and treatment of amblyopia and strabismus 

 

Outcome: Reject

 

NIHR201678: Development and pre-market evaluation of a non-invasive intracranial pressure monitor

 

Outcome: Reject

 

NIHR201624: Development of a Clinical Anti-Rheumatic Adherence Test (CARAT)

 

Outcome: Reject

 

NIHR201627: A Wearable Conditional Sacral Neuromodulator for Treatment of Lower Urinary Tract Dysfunction

 

Outcome: Reject

 

NIHR201631: FITSHAPE

 

Outcome: Reject

 

NIHR201630: Reducing risks of poor birth outcomes caused by placental dysfunction in Caucasian, African and Asian ethnicities in UK cities.

 

Outcome: Reject

 

NIHR201633: Clinical validation of a point of care device to aid wound infection diagnosis

 

Outcome: Reject

 

NIHR201636: ADAPT - An innovative system to de-risk and accelerate for complex surgery in the prone position

 

Outcome: Reject

 

NIHR201637: Robotic Inserted Cochlear Electrode (RICE)

 

Outcome: Reject

 

NIHR201638: An investigation into using whole breast radio wave scanning to guide further targeted investigation of a symptomatic breast using hand-held ultrasound

 

Outcome: Reject

 

NIHR201647: The use of MyCognitionPRO to improve functioning of primary care patients with Mild Cognitive Impairment (MCI)

 

Outcome: Reject

 

NIHR201648: Development & prospective study of AI-based diagnostic tool for more accurate, early diagnosis of prostate cancer

 

Outcome: Reject

 

NIHR201649: ViewEye: Digital platform technology for low-cost, automated retinal imaging

 

Outcome: Reject

 

NIHR201650: Postable Blood Test Device 

 

Outcome: Reject

 

NIHR201652: CENSEO – clinical evaluation of an online assessment tool for mental health diagnosis in primary care

 

Outcome: Reject

 

NIHR201653: Development of a real-time monitoring and diagnostics device for pre-transplantation organ assessment

 

Outcome: Reject

 

NIHR201656: K-Monitor: A continuous monitoring solution for lower limb prostheses

 

Outcome: Reject

 

NIHR201658: Development of a novel universal point-of-care diagnostic platform for comprehensive metabolic panel testing enabling healthcare efficiencies and improved detection and patient self-management of long-term conditions

 

Outcome: Reject

 

NIHR201659: Development of a transcutaneous vagal nerve stimulation to treat depression 

 

Outcome: Reject

 

NIHR201661: "ChronReg: The development and pilot/feasibility trial of a new digital biofeedback intervention for improving emotion self-regulation in young people with long-term chronic health conditions”

 

Outcome: Reject

 

NIHR201662: Personal lithium drug monitor

 

Outcome: Reject

 

NIHR201663: Use of 3D printing to manufacture personalised pharmaceutical products in NHS hospitals

 

Outcome: Reject

 

NIHR201666: Design and Manufacturing of Prosthesis in Additive Manufacturing

 

Outcome: Reject

 

NIHR201667: NeWTS: Neonatal Wireless Transmission System

 

Outcome: Reject

 

NIHR201668: Development and clinical evaluation of a wearable smart garment for long-term ambulatory heart rhythm monitoring

 

Outcome: Reject

 

NIHR201670: Immersive 4D imaging for Planning Surgical and Catheter Intervention in Structural Heart Disease

 

Outcome: Reject

 

NIHR201673: GaitThaw - improving the lives of people with Parkinson's

 

Outcome: Reject

 

NIHR201675: Development of a bed-side device for rapid profiling of the vaginal microbiome

 

Outcome: Reject

 

NIHR201681: Venous leg ulcers: co-design and development of a novel electronically-assisted, user adjusted, 'smart sock' to improve healing time of venous leg ulcers.

 

Outcome: Reject

 

NIHR201682: ELectrotherapy, Sensing and data Acquisition for joint pain management (ELSA)

 

Outcome: Reject

 

NIHR201685: Risk Assessment to reduce unintended consequences of Giant Cell Arteritis by rigorous, personalised, actuarial risk quantification and uncertainty management.

 

Outcome: Reject

 

NIHR201687: LUS in the Cloud: A Portable Solution for B-line Quantification in Lung Ultrasound Imaging

 

Outcome: Reject

 

NIHR201689: "Using an individual patient's resting brain activity as a predictor of future postsurgical pain."

 

Outcome: Reject

 

NIHR201691: Developing an artificial intelligence based software product that detects the clinical abnormalities in musculoskeletal X-rays as a decision support tool for the front-line clinicians

 

Outcome: Reject


Stage 1 application did not fulfil the Programme’s eligibility criteria:

NIHR201691: Developing an artificial intelligence based software product that detects the clinical abnormalities in musculoskeletal X-rays as a decision support tool for the front-line clinicians

 

Outcome: Reject